Stocks
Exelixis Financial Statements (EXEL) |
||||||||||
| Exelixissmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 09.05.2023 | 01.08.2023 | 01.11.2023 | 06.02.2024 | 30.04.2024 | 30.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 408.8 | 469.8 | 471.9 | 479.7 | 425.2 | 1 847 | |||
| Operating Income, bln rub | 22.0 | 77.9 | -17.6 | 81.8 | 29.5 | 171.5 | ||||
| EBITDA, bln rub | ? | 28.8 | 77.9 | -17.6 | 88.3 | 101.5 | 250.1 | |||
| Net profit, bln rub | ? | 40.0 | 81.2 | 1.04 | 85.5 | 37.3 | 205.1 | |||
| OCF, bln rub | ? | 84.4 | 121.0 | 117.4 | 10.6 | 68.8 | 317.7 | |||
| CAPEX, bln rub | ? | 48.5 | 7.44 | 93.9 | 13.1 | 18.2 | 132.6 | |||
| FCF, bln rub | ? | 35.9 | 113.5 | 23.5 | -2.56 | 50.6 | 185.1 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 365.6 | 392.0 | 470.7 | 376.1 | 341.7 | 1 581 | ||||
| Cost of production, bln rub | 14.3 | 17.7 | 18.8 | 21.8 | 21.3 | 79.5 | ||||
| R&D, bln rub | 234.2 | 232.6 | 332.6 | 244.7 | 227.7 | 1 038 | ||||
| Interest expenses, bln rub | 26.3 | 0.000 | 0.000 | 26.3 | 0.000 | 26.3 | ||||
| Assets, bln rub | 3 143 | 3 142 | 2 977 | 2 942 | 2 804 | 2 804 | ||||
| Net Assets, bln rub | ? | 2 555 | 2 528 | 2 348 | 2 264 | 2 128 | 2 128 | |||
| Debt, bln rub | 186.9 | 194.7 | 190.9 | 189.9 | 201.5 | 201.5 | ||||
| Cash, bln rub | 1 313 | 1 267 | 1 103 | 995.3 | 963.3 | 963.3 | ||||
| Net debt, bln rub | -1 126 | -1 072 | -912.5 | -805.4 | -761.8 | -761.8 | ||||
| Ordinary share price, rub | 19.4 | 19.1 | 21.9 | 24.0 | 23.7 | 20.1 | ||||
| Number of ordinary shares, mln | 324.4 | 324.2 | 315.5 | 308.5 | 300.8 | 300.8 | ||||
| Market cap, bln rub | 6 297 | 6 196 | 6 894 | 7 400 | 7 137 | 6 051 | ||||
| EV, bln rub | ? | 5 171 | 5 123 | 5 981 | 6 595 | 6 375 | 5 289 | |||
| Book value, bln rub | 2 491 | 2 464 | 2 284 | 2 200 | 2 064 | 2 064 | ||||
| EPS, rub | ? | 0.12 | 0.25 | 0.00 | 0.28 | 0.12 | 0.68 | |||
| FCF/share, rub | 0.11 | 0.35 | 0.07 | -0.01 | 0.17 | 0.62 | ||||
| BV/share, rub | 7.68 | 7.60 | 7.24 | 7.13 | 6.86 | 6.86 | ||||
| EBITDA margin, % | ? | 7.05% | 16.6% | -3.73% | 18.4% | 23.9% | 13.5% | |||
| Net margin, % | ? | 9.79% | 17.3% | 0.22% | 17.8% | 8.78% | 11.1% | |||
| FCF yield, % | ? | 1.87% | 3.43% | 1.95% | 2.30% | 2.59% | 3.06% | |||
| ROE, % | ? | 6.02% | 6.50% | 3.92% | 9.18% | 9.64% | 9.64% | |||
| ROA, % | ? | 4.89% | 5.23% | 3.09% | 7.06% | 7.31% | 7.31% | |||
| P/E | ? | 41.0 | 37.7 | 74.9 | 35.6 | 34.8 | 29.5 | |||
| P/FCF | 53.4 | 29.1 | 51.4 | 43.4 | 38.6 | 32.7 | ||||
| P/S | ? | 3.78 | 3.61 | 3.88 | 4.04 | 3.86 | 3.28 | |||
| P/BV | ? | 2.53 | 2.51 | 3.02 | 3.36 | 3.46 | 2.93 | |||
| EV/EBITDA | ? | 32.8 | 34.9 | 145.8 | 37.2 | 25.5 | 21.2 | |||
| Debt/EBITDA | -7.15 | -7.30 | -22.2 | -4.54 | -3.05 | -3.05 | ||||
| R&D/CAPEX, % | 482.7% | 3 127% | 354.3% | 1 863% | 1 252% | 782.2% | ||||
| CAPEX/Revenue, % | 11.9% | 1.58% | 19.9% | 2.74% | 4.28% | 7.18% | ||||
| Exelixis shareholders | ||||||||||
